🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to describe quality of life in hereditary or acquired non d...
Status
Completed
Location
CHU Besançon
Start Date
2016-07-11
Trial ID
NCT03240991
Treatments Being Tested
The proposed project will examine the effects of a healing touch interventi...
Status
Completed
Location
Multiple Locations
Start Date
2001-06-04
Trial ID
NCT04905576
Treatments Being Tested
This research trial studies saliva, semen, and blood samples to determine e...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-12-06
Trial ID
NCT03206450
Treatments Being Tested
Administration of systemic corticosteroids for patients with severe forms o...
Status
Unknown
Location
University Hospital Brno
Start Date
2021-02-16
Trial ID
NCT04648410
Treatments Being Tested
The purpose of the study is to demonstrate that systematic self measurement...
Status
Completed
Location
Temple University Hospital
Start Date
2010-11
Trial ID
NCT01212159
Treatments Being Tested
Fluid responsiveness assessment is a major issue in intensive care. Since f...
Status
Completed
Location
Site Sud - CHU d'Amiens Picardie
Start Date
2024-03-19
Trial ID
NCT07073859
Treatments Being Tested
The purpose of this study is to determine whether wireless transmission of ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01373996
Treatments Being Tested
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713